In the development of drug biomarkers have become very important. For the discovery of protein biomarkers the usage of mass spectrometry and quantitative proteomics has increased widely. The protein identification helps to understand the mechanism of the tumor metastasis and thus facilitates the drug development/interventions of cancer. Along with the other branches of science like biochemistry, molecular genetics, cell biology with proteomics help in studying the cancer metastasis and improvement of the methodologies. Thus, helping researchers in the discovery of biomarkers and pathogenetic studies.
Last date updated on October, 2020